Guard Therapeutics International AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was SEK 113.32 million compared to SEK 112.84 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.4 SEK | -4.70% | -1.39% | -20.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.67% | 27.35M | |
+1.51% | 42.75B | |
+49.00% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GUARD Stock
- News Guard Therapeutics International AB
- Guard Therapeutics International AB Reports Earnings Results for the Full Year Ended December 31, 2023